Juvenescence Ltd - Feb 3, 2022 Form 4 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
10%+ Owner
Signature
/s/ Gregory Bailey, CEO
Stock symbol
AGE
Transactions as of
Feb 3, 2022
Transactions value $
$0
Form type
4
Date filed
2/14/2022, 03:42 PM
Next filing
Mar 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Warrant to Purchase Common Stock Purchase $0 +309K $0.00 309K Feb 3, 2022 Common Stock 309K $0.81 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Warrants issued in connection with the draw of loan funds under a Secured Convertible Facility Agreement between the issuer and the reporting person.
F2 The warrants are exercisable for shares of the issuer's common stock upon issuance.